Antipsychotic Drug Misuse Lands Johnson & Johnson on the Wrong End of Federal Suit
“In the federal suit, Johnson & Johnson is accused not just of promoting Risperdal for patients without psychosis but of providing kickbacks to Omnicare, a middleman that supplied drugs to nursing homes and advised doctors what to prescribe. Last fall, Omnicare settled its part of the suit for $98 million.” The Boston Globe, Monday March … Read more
HP “Buyer Incentives” and Off-Label Prescription Sales: Are there any good apples left to spoil the maleficence barrel?
Posted by piblogger on May 19, 2010 · Comments Off
“In many foreign countries, particularly in those with developing economies, it is common to engage in business practices that are prohibited by laws and regulations applicable to us, such as the Foreign Corrupt Practices Act. Although we implement policies and procedures designed to facilitate compliance with these laws, our employees, contractors and agents, as well … Read more
Rate this:
Filed under Commentary/Article · Tagged with AstraZeneca, FCPA, Hewlett-Packard, HP. off-label drugs, Johnson & Johnson, Risperdal